MedPath

A study to see the effect of antioxidants(vitamins and minerals that protect our cells) on scarring of the pancreas in patients with chronic pancreatitis

Not Applicable
Recruiting
Conditions
Patients of chronic pancreatitis
Registration Number
CTRI/2011/05/001747
Lead Sponsor
AIIMS
Brief Summary

This study is a randomised control trial to see the effect of a combination of antioxidants for 3 months on markers of fibrosis in 80 patients of chronic pancreatitis.The primary outcome measures will be surrogate markers of fibrosis. The secondary outcome measures will be markers of oxidative stress and antioxidant levels.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
60
Inclusion Criteria

All the treatment naïve patient with Chronic Pancreatitis.

Exclusion Criteria
  • 1.Complications like pseudocyst, pancreatic abscess, pseudoaneurysm, pancreatic fistula 2.Comorbid conditions like liver diseases,renal failure,pulmonary fibrosis.
  • 3.Patient with adenocarcinoma of pancreas, acute on chronic pancreatitis.
  • 4.Pregnant and lactating female 5.Age less than 12 years 6.Inability to give informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Surrogate markers of pancreatic fibrosis: TGF-beta 1,PDGF, fibronectin and pro-collagen IIIat baseline and 3 months of intervention
Secondary Outcome Measures
NameTimeMethod
Markers of oxidative stress: TBARS, Serum SOD Marker of antioxidant capacity or defense: Total glutathione, Ferric Reducing Assay of Plasma (FRAP)at baseline and 3 months after intervention

Trial Locations

Locations (1)

AIIMS

🇮🇳

South, DELHI, India

AIIMS
🇮🇳South, DELHI, India
DR ANOOP SARAYA
Principal investigator
11-26593294
ansaraya@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.